Background: The role of conventional liver function clinical laboratory marker De Ritis Ratio in evaluating the prognosis, assisting diagnosis, and monitoring therapeutic efficacy of cancer is gaining increasing attention, especially in the last decade. According to the most recent articles, the De Ritis Ratio functions have progressed, which indicates that the De Ritis Ratio appears to be a promising tumor marker. The aim of this review was to evaluate the clinical importance from studies made on this subject.
Methods: Using the search words "De Ritis Ratio", "aspartate transaminase/alanine transaminase", "aspartate transaminase", "alanine transaminase", "cancer", "prognostic significance", "diagnostic significance", and "predictive significance", a search was carried out on PubMed. Exclusion criteria were articles never published in English and articles evaluating tumor markers in cancer not involving the De Ritis Ratio.
Results: As a predictor of prognosis, the De Ritis Ratio is strongly associated with prognostic risk factors and can be used to assess therapeutic efficacy. As a predictor of incidence, the De Ritis Ratio could promote the prediction of the disease progression. As a biomarker, the De Ritis Ratio is more likely to improve diagnostics by being combined with other biomarkers. Therefore, since it is easily accessible, involves no additional laborious efforts, and is a relatively inexpensive marker, the De Ritis Ratio is emerging as an attractive and clinically valuable marker in cancer.
Conclusions: In the review, we explore the possible mechanisms of the De Ritis Ratio related to cancer and summarize the clinical importance of the De Ritis Ratio as a promising marker for cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7754/Clin.Lab.2023.230528 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Do the ınflammatory markers have a prognostic role in an elderly patient population diagnosed with non-muscle ınvasive bladder cancer?
Cir Cir
January 2025
Department of Urology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.
Objective: To evaluate whether the systemic immune-inflammation index (SII), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and De-Ritis ratio (DRR) are determinants of progression-free survival (PFS), recurrence-free survival (RFS) and overall survival (OS) in patients aged ≥ 70 years diagnosed with non-muscle invasive bladder cancer (NMIBC).
Method: The study included 173 elderly patients diagnosed with NMIBC between January 2015 and March 2022. The clinical and pathological data of the patients were examined.
Analysis of Calculated Liver Scores for Long-Term Outcome in 423 Cutaneous Melanoma Patients.
Cancers (Basel)
September 2024
Skin Cancer Center, Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, 44791 Bochum, Germany.
Article Synopsis
- Neoadjuvant and adjuvant therapies are becoming increasingly important in treating cutaneous melanoma (CM), but there is still a need for better prognostic tools to identify patients at high risk.
- Recent evidence suggests that liver scores could serve as potential prognostic indicators across various tumor types, prompting an investigation into their relevance for CM prognosis.
- A study involving 423 patients demonstrated that while tumor thickness and ulceration were key predictors of survival across all stages, liver scores like the APRI showed significant associations with survival outcomes specifically in earlier stages (I and II) of melanoma.
Biomarkers of oxidative stress, biochemical changes, and the activity of lysosomal enzymes in the livers of rainbow trout ( Walbaum) vaccinated against yersiniosis before a challenge.
J Vet Res
September 2024
Department of Zoology, Institute of Biology, Pomeranian University in Słupsk, 76-200 Słupsk, Poland.
Introduction: This study aimed to evaluate biomarkers of oxidative stress (2-thiobarbituric acid reactive substances, aldehyde and ketone derivatives of oxidatively modified proteins and total antioxidant capacity), the activity of antioxidant enzymes (superoxide dismutase, catalase, glutathione reductase and glutathione peroxidase), that of lysosomal enzymes (alanyl aminopeptidase, leucyl aminopeptidase, β-N-acetylglucosaminidase and acid phosphatase) and changes in biochemical parameters (alanine aminotransferase, aspartate aminotransferase, de Ritis ratio, lactate dehydrogenase activity, lactate and pyruvate levels and their ratio) in the liver tissue of fish that were vaccinated against enteric redmouth disease and challenged with its causative agent, the bacterium .
Material And Methods: The vaccine was administered orally to trout, some of which were challenged with 61 days later. For comparison, unvaccinated and unchallenged trout and unvaccinated and challenged trout were also evaluated.
Blood-, Tissue- and Urine-Based Prognostic Biomarkers of Upper Tract Urothelial Carcinoma.
Diagnostics (Basel)
August 2024
University Center of Excellence in Urology, Wrocław Medical University, 50-556 Wrocław, Poland.
Article Synopsis
- Upper tract urothelial carcinoma (UTUC) is an aggressive cancer with limited reliable prognostic biomarkers currently available.
- A thorough review of 94 studies assessed the prognostic value of various biomarkers from blood, tissue, and urine in UTUC patients, focusing on 22 blood-based, 13 tissue-based, and 4 urine-based markers.
- While certain biomarkers like the neutrophil-lymphocyte ratio and albumin are well-supported and included in existing guidelines, the clinical significance of many other potential biomarkers needs further investigation due to insufficient research.
Navigating Disease Management: A Comprehensive Review of the De Ritis Ratio in Clinical Medicine.
Cureus
July 2024
Internal Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
The De Ritis ratio, defined as the serum aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio, is a widely recognized biochemical marker with significant applications in diagnosing and managing various diseases, particularly liver disorders. This comprehensive review synthesizes current knowledge surrounding the clinical relevance of the De Ritis ratio, examining its historical development, diagnostic utility, and prognostic significance across various medical conditions, including liver diseases, cardiovascular disorders, and muscular pathologies. Through an in-depth analysis of literature spanning several decades, this review highlights the role of the De Ritis ratio not only in differential diagnosis but also as a prognostic indicator for disease progression and patient outcomes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!